what are glp 1 agonists GLP-1 Agonists: A Comprehensive Overview Current Insights, Advantages and Challenges
Description
Moreover, some trials revealed improvements in cardiovascular risk markers such as BNP and CRP
Each treatment group was divided into two cages with three mice in each cage
LTP, long-term enhancement
Mounjaro is tirzepatide a different molecule with different trial data
On the other hand, cardiovascular tissues react to GLP-1 via activated survival pathways, indicating possible protective benefits
Obesity has been implicated as promoting cardiovascular disease, diabetes, hypertension, and other complications, suggesting that sustained, effective weight loss may have independent cardiovascular benefit [13] [14]
